We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$3.3B
AUM Growth
+$481M
(+17%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
15.52%
Top 10 Holdings %
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
188
Closed
428
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$41.4M |
| 2 |
XLRN
Acceleron Pharma
XLRN
|
+$7.85M |
| 3 |
Bausch Health
BHC
|
+$7.4M |
| 4 |
Albemarle
ALB
|
+$6.62M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$6.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$24.4M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$10M |
| 3 |
Amgen
AMGN
|
+$7.37M |
| 4 |
Cracker Barrel
CBRL
|
+$5.6M |
| 5 |
Costco
COST
|
+$5.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.28% |
| 2 | Communication Services | 1.55% |
| 3 | Technology | 0.91% |
| 4 | Consumer Discretionary | 0.74% |
| 5 | Financials | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
PUT
Corcept Therapeutics
CORT
$9.98B
| $935K | 0.03% |
47,500
-85,000
| -64% | -$1.78M |
|
477
Arrowhead Research
ARWR
$12.1B
| $927K | 0.03% |
+14,849
| New | +$961K |
|
478
PUT
Scorpio Tankers
STNG
$3.91B
| $927K | 0.03% |
50,000
| – | – |
|
479
Adobe
ADBE
$105B
| $921K | 0.03% |
1,600
+600
| +60% | +$378K |
|
|
FL
480
PUT
DELISTED
Foot Locker
FL
| $913K | 0.03% |
20,000
| – | – |
|
|
ISEE
481
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $913K | 0.03% |
+56,200
| New | +$612K |
|
482
CALL
Pinduoduo
PDD
$126B
| $907K | 0.03% |
10,000
-10,000
| -50% | -$973K |
|
483
PUT
Domino's
DPZ
$11.9B
| $906K | 0.03% |
+1,900
| New | +$962K |
|
484
CALL
Freeport-McMoran
FCX
$86.2B
| $901K | 0.03% |
27,700
-159,300
| -85% | -$5.61M |
|
485
CALL
B&G Foods
BGS
$303M
| $897K | 0.03% |
+30,000
| New | +$900K |
|
|
JAMF
486
CALL
DELISTED
Jamf
JAMF
| $894K | 0.03% |
+23,200
| New | +$796K |
|
487
CALL
Altimmune
ALT
$568M
| $887K | 0.03% |
+78,400
| New | +$953K |
|
488
CALL
Roblox
RBLX
$35.9B
| $869K | 0.03% |
+11,500
| New | +$944K |
|
489
PUT
Alerian MLP ETF
AMLP
$12.9B
| $867K | 0.03% |
26,000
+14,800
| +132% | +$494K |
|
490
Lam Research
LRCX
$316B
| $854K | 0.03% |
+15,000
| New | +$912K |
|
|
SOS
491
CALL
SOS Limited
SOS
$17.2M
| $852K | 0.03% |
533
-194
| -27% | -$389K |
|
492
PUT
CVS Health
CVS
$135B
| $849K | 0.03% |
10,000
| – | – |
|
493
CALL
Globalstar
GSAT
$10.1B
| $835K | 0.03% |
33,333
-83,707
| -72% | -$2.05M |
|
494
Global X Uranium ETF
URA
$5.21B
| $833K | 0.03% |
+35,000
| New | +$745K |
|
495
Sarepta Therapeutics
SRPT
$1.64B
| $832K | 0.03% |
+9,000
| New | +$693K |
|
496
Quince Therapeutics
QNCX
$21.5M
| $825K | 0.03% |
+45
| New | +$716K |
|
497
CALL
TAL Education Group
TAL
$6.04B
| $823K | 0.02% |
170,000
-1,565,200
| -90% | -$13.9M |
|
498
CALL
SPDR Gold Trust
GLD
$131B
| $821K | 0.02% |
5,000
| – | – |
|
499
CALL
Global X Lithium & Battery Tech ETF
LIT
$1.46B
| $820K | 0.02% |
+10,000
| New | +$820K |
|
|
500
PUT
Global X Lithium & Battery Tech ETF
LIT
$1.46B
| $820K | 0.02% |
+10,000
| New | +$820K |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q3 2021 Portfolio in Review
As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
SG3 Management deployed $512M of net new capital in Q3 2021, opening 403 new positions and adding to 148 existing holdings. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.3% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was Bank of America, an estimated $4.85M trimmed.
- SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
- SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
- SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
- SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
- SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
- SG3 Management opened 403 new positions and closed 428 in Q3 2021.
- SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.
Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.